Insulins (all types): risk of cutaneous amyloidosis at injection site

2020-09-23T14:27:36+01:00

Cutaneous amyloidosis at the injection site has been reported in patients using insulin and this may affect glycaemic control. Remind patients to rotate injection sites within the same body region.